Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001050581 | SCV001214696 | pathogenic | Hereditary diffuse gastric adenocarcinoma | 2021-03-10 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with CDH1-related conditions. ClinVar contains an entry for this variant (Variation ID: 847107). For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CDH1 are known to be pathogenic (PMID: 15235021, 20373070). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Trp638*) in the CDH1 gene. It is expected to result in an absent or disrupted protein product. |
Myriad Genetics, |
RCV001050581 | SCV004044180 | pathogenic | Hereditary diffuse gastric adenocarcinoma | 2023-06-14 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. |
Baylor Genetics | RCV003473642 | SCV004210564 | likely pathogenic | Familial cancer of breast | 2022-06-21 | criteria provided, single submitter | clinical testing |